Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pliaglis in Postherpetic Neuralgia
NCT00609323Phase 2Completed
- Sponsor
- ZARS Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of lidocaine + tetracaine in postherpetic neuralgia (PHN) (2 arms), sponsored by ZARS Pharmaceuticals. Primary endpoints: Numeric Pain Rating Scale, Area of allodynia and 2 more. Started Jan 2008; status: completed.
02
Drugs
lidocaine + tetracaine
03
Conditions
postherpetic neuralgia (PHN)
Beyond the preview
Go deeper on NCT00609323.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609323.